A SHORT REVIEW ON POLYCYSTIC OVARY SYNDROME

Authors

  • Kavitha A acharya nagarjuna university
  • VEENA KIRAN S Department of Pharmacology, Chalapathi Institute of Pharmaceutical Sciences, Lam, Guntur - 522 034, Andhra Pradesh, India.
  • SIRISHA K Department of Pharmacology, Chalapathi Institute of Pharmaceutical Sciences, Lam, Guntur - 522 034, Andhra Pradesh, India.
  • NARENDRA BABU A Department of Pharmacology, Chalapathi Institute of Pharmaceutical Sciences, Lam, Guntur - 522 034, Andhra Pradesh, India.
  • SATHISH KUMAR M Department of Pharmacology, Chalapathi Institute of Pharmaceutical Sciences, Lam, Guntur - 522 034, Andhra Pradesh, India.

Abstract

Polycystic ovary syndrome (PCOS) is said to be the commonest endocrine disorder in women of reproductive age with a heterogeneous presentation, which includes hyperandrogenism and ovulatory dysfunction. Polycystic ovary syndrome usually has a peri-pubertal onset;the present review discuss about the causes,complications,risck factors,dianosis and treatment.

Key words:Polycystic ovary syndrome (PCOS),Hyperandrogenism,Treatment

Author Biography

Kavitha A, acharya nagarjuna university

m.pharm pharmacology,rank 2

References

Polycystic ovary syndrome (PCOS) is said to be the commonest endocrine disorder in women of reproductive age with a heterogeneous presentation, which includes hyperandrogenism and ovulatory dysfunction. Polycystic ovary syndrome usually has a peri-pubertal onset;the present review discuss about the causes,complications,risck factors,dianosis and treatment.

Key words:Polycystic ovary syndrome (PCOS),Hyperandrogenism,Treatment

Published

01-04-2016

How to Cite

A, K., KIRAN S, V., K, S., BABU A, N., & M, S. K. (2016). A SHORT REVIEW ON POLYCYSTIC OVARY SYNDROME. Innovare Journal of Medical Sciences, 4(2), 6–10. Retrieved from https://journals.innovareacademics.in/index.php/ijms/article/view/7728

Issue

Vol 4 Issue 2 2016 ( April - May)

Section

Review Article(s)